COL17A1 and Alzheimer disease: When different fusion proteins (FP1-FP13) covering BP180 (Figures 1A,B) were employed, BP sera preferentially reacted with the extracellular fragment FP5, corresponding to the NC16A domain, while there was no reactivity in sera of patients with multiple sclerosis, Alzheimer’s disease and healthy controls.